Description
Denik Pharm INSUGRO (IGF-1 LR3) 125 mcg is a premium long-acting Insulin-Like Growth Factor-1 Long R3 (IGF-1 LR3) research peptide developed for scientists exploring the intricate biology of cellular proliferation, tissue regeneration, and growth factor signaling. Through strategic molecular modification, IGF-1 LR3 exhibits prolonged biological activity and enhanced receptor availability, making it one of the most valuable growth factor analogues in modern peptide research.
Unlike native IGF-1, IGF-1 LR3 has been engineered to exhibit reduced affinity for Insulin-Like Growth Factor Binding Proteins (IGFBPs), allowing researchers to investigate sustained receptor activation and extended intracellular signaling. This unique characteristic has established INSUGRO as an important research tool for laboratories studying regenerative biology, skeletal muscle physiology, protein synthesis, and the molecular pathways responsible for cellular growth and adaptation.
Each package contains 5 lyophilized vials, with 125 mcg of IGF-1 LR3 per vial, providing a high-purity formulation designed for advanced scientific investigations. Manufactured by Denik Pharm, INSUGRO is produced under strict pharmaceutical-quality standards to ensure exceptional purity, stability, and batch-to-batch consistency for reliable laboratory performance.
Key Features
- Premium Insulin-Like Growth Factor-1 Long R3 (IGF-1 LR3)
- 125 mcg of high-purity peptide per vial
- 5 lyophilized vials per pack
- Long-acting IGF-1 analogue with enhanced biological stability
- Reduced affinity for IGF Binding Proteins (IGFBPs)
- High-purity laboratory-grade formulation
- Extensively researched in regenerative biology and growth factor science
- Suitable for investigations involving cellular proliferation, protein synthesis, tissue regeneration, and molecular signaling
- Manufactured under rigorous pharmaceutical-quality standards
- Intended exclusively for laboratory and scientific research applications
How It Works
IGF-1 LR3 binds to the IGF-1 receptor (IGF-1R), initiating intracellular signaling pathways that regulate cellular growth, survival, and differentiation. Its modified molecular structure reduces interaction with IGF Binding Proteins (IGFBPs), enabling researchers to investigate prolonged receptor activation and sustained biological responses under controlled laboratory conditions.
In scientific studies, INSUGRO is frequently utilized to examine key signaling networks, including the PI3K/Akt and MAPK/ERK pathways, which play central roles in protein synthesis, cellular proliferation, tissue remodeling, and regenerative physiology. Researchers also investigate its effects on satellite cell activation, growth factor communication, and skeletal muscle biology, making IGF-1 LR3 one of the most extensively studied peptides in molecular endocrinology and regenerative medicine.
This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.
Contents
Active Ingredient: Insulin-Like Growth Factor-1 Long R3 (IGF-1 LR3) – 125 mcg
Packaging: 5 Lyophilized Vials
Reviews
There are no reviews yet.